 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) had its price objective dropped by equities research analysts at BTIG Research from $6.00 to $5.00 in a note issued to investors on Thursday...

Adaptive Biotechnologies (NASDAQ:ADPT) PT Lowered to $5.00

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Adaptive Biotechnologies sees Q1 revenue $41M-$43M, consensus $38.2M

Adaptive Biotechnologies announces CFO transition

Adaptive Biotechnologies concludes strategic review, will operate MRD internally

F5 Chief People Officer Lyra Schramm (left) and Chief Technology Officer Kunal Anand. (F5 Photos)

 Seattle-based application security and delivery giant F5 announced two new executive appointments...

Tech Moves: F5 adds CTO and HR chief; Adaptive names CFO; Techstars Seattle leaders depart

Announces CFO transitionSEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

Francis Lo, chief people officer at Adaptive Biotechnologies, accepts the Workplace of the Year Award at the 2023 GeekWire Awards. (GeekWire File Photo / Kevin Lisota)

Respect. Inclusion...

Vote for Workplace of the Year: Startups employ various methods in their commitment to culture

SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

This is a signal that ADPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Adaptive Biotechnologies (ADPT, $3.27) RSI Indicator left the oversold zone on March 19, 2024

Adaptive Biotechnologies (ADPT, $3.18) RSI Indicator left the oversold zone on March 18, 2024

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Volume (M)	2.78M
52-Wk High	$9.08
52-Wk Low	$2.53

ADPT Adaptive Biotechnologies Corp

About

Feed

News

Sentiment

Earnings

Fundamentals